The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on available information, the reported failure to advance sgc (steerable guide catheter) across the septum appears to be related to challenging anatomy with rotated heart.A cause of the reported bleeding (femoral vein) could not be determined.The reported patient effect of hemorrhage, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported that a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 3+, rotated heart, and enlarged left atrium.Trannseptal access was difficult due to the patient¿s rotated heart axis and very small membranous foramen ovale.After successful transseptal puncture, a steerable guide catheter (sgc) was inserted, but while advancing towards the left atrium (la), the sgc was tenting on the septum, and bleeding from the vena femoralis was observed.Therefore, advancing the sgc was stopped, and pressure was applied on the groin.After ten minutes, the bleeding was not stopping.Therefore, the sgc was retracted and removed from the patient.The bleeding of the femoral vein was treated with a z-suture, which stopped the bleeding.The procedure was discontinued with no clips implanted.The mr remained at a grade of 3+.It was noted that in the physician's opinion, it was not certain what the exact cause for the bleeding was, but the bleeding was potentially due to guide insertion, as the bleeding occurred shortly after.There was no clinically significant delay in the procedure.
|